These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33257449)

  • 1. Validation of a Community-Acquired Pneumonia Score To Improve Empiric Antibiotic Selection at an Academic Medical Center.
    Oliver MB; Fong K; Certain L; Spivak ES; Timbrook TT
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33257449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-acquired pneumonia with risk for drug-resistant pathogens.
    Fleming V; Buck B; Nix N; Kumar P; Southwood R
    South Med J; 2013 Mar; 106(3):209-16. PubMed ID: 23462490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Validation of Drug Resistance in Pneumonia (DRIP) Score in Predicting Infections due to Drug-Resistant Pathogens in Community-acquired Pneumonia at Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
    Fadrian F; Chen K; Kumalawati J; Rumende CM; Shatri H; Nelwan EJ
    Acta Med Indones; 2021 Oct; 53(4):416-422. PubMed ID: 35027488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model.
    Webb BJ; Dascomb K; Stenehjem E; Dean N
    Respir Med; 2015 Jan; 109(1):1-10. PubMed ID: 25468412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for prediction of drug-resistant pathogens and empiric antibiotic selection in community-acquired pneumonia.
    Gil R; Webb BJ
    Curr Opin Pulm Med; 2020 May; 26(3):249-259. PubMed ID: 32101906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic Use and Outcomes After Implementation of the Drug Resistance in Pneumonia Score in ED Patients With Community-Onset Pneumonia.
    Webb BJ; Sorensen J; Mecham I; Buckel W; Ooi L; Jephson A; Dean NC
    Chest; 2019 Nov; 156(5):843-851. PubMed ID: 31077649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of Drug Resistance in Pneumonia (DRIP) Score as Empirical Antibiotic Failure Predictor in Community-Acquired Pneumonia Patients in Cipto Mangunkusumo Hospital.
    Simanjuntak RB; Lie KC; Rumende CM; Abdullah M; Shatri H; Koesnoe S; Nainggolan L; Rizka A
    Acta Med Indones; 2024 Jan; 56(1):55-62. PubMed ID: 38561875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictors of drug-resistant pathogens in community-onset pneumonia: Are factors considered in health-care-associated pneumonia useful in the emergency department?].
    Torres Bonafonte OH; Gil Olivas E; Pérez Macho E; Pacho Pacho C; Mateo Roca M; Casademont Pou J; Ruiz Hidalgo D
    Emergencias; 2017 Oct; 29(5):306-312. PubMed ID: 29077289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a Prediction Score for Drug-Resistant Microorganisms in Community-acquired Pneumonia.
    Ceccato A; Mendez R; Ewig S; de la Torre MC; Cilloniz C; Gabarrus A; Prina E; Ranzani OT; Ferrer M; Almirall J; Menendez R; Torres A
    Ann Am Thorac Soc; 2021 Feb; 18(2):257-265. PubMed ID: 32915057
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of Risk Factors for Multidrug-Resistant Organisms in Community-Acquired Bacterial Pneumonia at a Community Hospital.
    Covington EW; Rufe A
    J Pharm Pract; 2023 Apr; 36(2):303-308. PubMed ID: 34406082
    [No Abstract]   [Full Text] [Related]  

  • 11. Derivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction Score.
    Webb BJ; Dascomb K; Stenehjem E; Vikram HR; Agrwal N; Sakata K; Williams K; Bockorny B; Bagavathy K; Mirza S; Metersky M; Dean NC
    Antimicrob Agents Chemother; 2016 May; 60(5):2652-63. PubMed ID: 26856838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empiric antibiotic selection and risk prediction of drug-resistant pathogens in community-onset pneumonia.
    Webb BJ; Jones B; Dean NC
    Curr Opin Infect Dis; 2016 Apr; 29(2):167-77. PubMed ID: 26886179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia.
    Amati F; Bindo F; Stainer A; Gramegna A; Mantero M; Nigro M; Bussini L; Bartoletti M; Blasi F; Aliberti S
    Adv Respir Med; 2023 May; 91(3):224-238. PubMed ID: 37366804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivation and Validation of a Clinical Prediction Score to Identify the Isolation of Pseudomonas in Pneumonia.
    Maskov Y; Sanders JM; Tilahun B; Hennessy SA; Reisch J; Johns M
    Microbiol Spectr; 2022 Jun; 10(3):e0042422. PubMed ID: 35604182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of community-acquired pneumonia.
    Lee YR; Houngue C; Hall RG
    Expert Rev Anti Infect Ther; 2015; 13(9):1109-21. PubMed ID: 26091895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for community-onset pneumonia caused by drug-resistant pathogens: A prospective cohort study.
    Barreto JV; Dias CC; Cardoso T
    Eur J Intern Med; 2022 Feb; 96():66-73. PubMed ID: 34670681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting antibiotic resistance to community-acquired pneumonia antibiotics in culture-positive patients with healthcare-associated pneumonia.
    Madaras-Kelly KJ; Remington RE; Fan VS; Sloan KL
    J Hosp Med; 2012 Mar; 7(3):195-202. PubMed ID: 22038859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derivation and validation of a risk assessment model for drug-resistant pathogens in hospitalized patients with community-acquired pneumonia.
    Rothberg MB; Haessler S; Deshpande A; Yu PC; Lindenauer PK; Zilberberg MD; Higgins TL; Imrey PB
    Infect Control Hosp Epidemiol; 2023 Jul; 44(7):1143-1150. PubMed ID: 36172877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simulated Adoption of 2019 Community-Acquired Pneumonia Guidelines Across 114 Veterans Affairs Medical Centers: Estimated Impact on Culturing and Antibiotic Selection in Hospitalized Patients.
    Christensen MA; Nevers M; Ying J; Haroldsen C; Stevens V; Jones MM; Yarbrough PM; Goetz MB; Restrepo MI; Madaras-Kelly K; Samore MH; Jones BE
    Clin Infect Dis; 2021 Jan; 72(Suppl 1):S59-S67. PubMed ID: 33512530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Impact of Hospital-acquired Pneumonia Guidelines on Empiric Antibiotics. An Evaluation of 113 Veterans Affairs Medical Centers.
    Bostwick AD; Jones BE; Paine R; Goetz MB; Samore M; Jones M
    Ann Am Thorac Soc; 2019 Nov; 16(11):1392-1398. PubMed ID: 31385720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.